Charbonnier Jean-Baptiste, Renaud Emilie, Miron Simona, Le Du Marie Hélène, Blouquit Yves, Duchambon Patricia, Christova Petya, Shosheva Alexandra, Rose Thierry, Angulo Jaime F, Craescu Constantin T
Laboratoire de Biologie Structurale et Radiobiologie, iBiTec-S, CEA, Commissariat à l'Energie Atomique, 91191 Gif-sur-Yvette, France.
J Mol Biol. 2007 Nov 2;373(4):1032-46. doi: 10.1016/j.jmb.2007.08.046. Epub 2007 Aug 25.
Human centrin 2 (HsCen2), an EF-hand calcium binding protein, plays a regulatory role in the DNA damage recognition during the first steps of the nucleotide excision repair. This biological action is mediated by the binding to a short fragment (N847-R863) from the C-terminal region of xeroderma pigmentosum group C (XPC) protein. This work presents a detailed structural and energetic characterization of the HsCen2/XPC interaction. Using a truncated form of HsCen2 we obtained a high resolution (1.8 A) X-ray structure of the complex with the peptide N847-R863 from XPC. Structural and thermodynamic analysis of the interface revealed the existence of both electrostatic and apolar inter-molecular interactions, but the binding energy is mainly determined by the burial of apolar bulky side-chains into the hydrophobic pocket of the HsCen2 C-terminal domain. Binding studies with various peptide variants showed that XPC residues W848 and L851 constitute the critical anchoring side-chains. This enabled us to define a minimal centrin binding peptide variant of five residues, which accounts for about 75% of the total free energy of interaction between the two proteins. Immunofluorescence imaging in HeLa cells demonstrated that HsCen2 binding to the integral XPC protein may be observed in living cells, and is determined by the same interface residues identified in the X-ray structure of the complex. Overexpression of XPC perturbs the cellular distribution of HsCen2, by inducing a translocation of centrin molecules from the cytoplasm to the nucleus. The present data confirm that the in vitro structural features of the centrin/XPC peptide complex are highly relevant to the cellular context.
人中心蛋白2(HsCen2)是一种EF手型钙结合蛋白,在核苷酸切除修复第一步的DNA损伤识别中发挥调节作用。这种生物学作用是通过与着色性干皮病C组(XPC)蛋白C端区域的一个短片段(N847-R863)结合来介导的。这项工作对HsCen2/XPC相互作用进行了详细的结构和能量表征。使用HsCen2的截短形式,我们获得了与XPC的肽N847-R863形成的复合物的高分辨率(1.8 Å)X射线结构。对界面的结构和热力学分析揭示了静电和非极性分子间相互作用的存在,但结合能主要由非极性大侧链埋入HsCen2 C端结构域的疏水口袋中决定。对各种肽变体的结合研究表明,XPC残基W848和L851构成关键的锚定侧链。这使我们能够定义一个由五个残基组成的最小中心蛋白结合肽变体,其占两种蛋白质之间总相互作用自由能的约75%。HeLa细胞中的免疫荧光成像表明,在活细胞中可以观察到HsCen2与完整的XPC蛋白结合,并且由复合物X射线结构中确定的相同界面残基决定。XPC的过表达通过诱导中心蛋白分子从细胞质向细胞核的转运来扰乱HsCen2的细胞分布。目前的数据证实,中心蛋白/XPC肽复合物的体外结构特征与细胞环境高度相关。